These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3487906)

  • 1. Chronic relapsing experimental allergic neuritis in Lewis rats: effects of thymectomy and splenectomy.
    Craggs RI; Brosnan JV; King RH; Thomas PK
    Acta Neuropathol; 1986; 70(1):22-9. PubMed ID: 3487906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropathological findings in chronic relapsing experimental allergic neuritis induced in the Lewis rat by inoculation with intradural root myelin and treatment with low dose cyclosporin A.
    McCombe PA; van der Kreek SA; Pender MP
    Neuropathol Appl Neurobiol; 1992 Apr; 18(2):171-87. PubMed ID: 1620277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of prophylactic cyclosporin A on experimental allergic neuritis (EAN) in the Lewis rat. Induction of relapsing EAN using low dose cyclosporin A.
    McCombe PA; van der Kreek SA; Pender MP
    J Neuroimmunol; 1990 Jul; 28(2):131-40. PubMed ID: 2362014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of myelin P2 protein in the production of experimental allergic neuritis.
    Rostami A; Brown MJ; Lisak RP; Sumner AJ; Zweiman B; Pleasure DE
    Ann Neurol; 1984 Dec; 16(6):680-5. PubMed ID: 6084458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced susceptibility of T cell-deficient rats to induction of experimental allergic neuritis.
    Brosnan JV; Craggs RI; King RH; Thomas PK
    J Neuroimmunol; 1987 Apr; 14(3):267-82. PubMed ID: 3494041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneous chemiluminescence activity of peripheral blood cells during experimental allergic neuritis (EAN).
    Stevens A; Lang R; Schabet M; Wiethölter H; Hammann K
    J Neuroimmunol; 1990 Apr; 27(1):33-40. PubMed ID: 2318955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gangliosides improve the outcome of experimental allergic neuritis (EAN).
    Oderfeld-Nowak B; Brosnan C; Cervone A; Oderfeld J; Ledeen RW
    Acta Neurobiol Exp (Wars); 1990; 50(4-5):495-504. PubMed ID: 2130664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous remission of autoimmune encephalomyelitis is inhibited by splenectomy, thymectomy or ageing.
    Ben-Nun A; Ron Y; Cohen IR
    Nature; 1980 Nov; 288(5789):389-90. PubMed ID: 6159555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of acute phase and inhibition of chronic phase of experimental autoimmune neuritis in Lewis rats by intranasal administration of recombinant mouse interleukin 17: potential immunoregulatory role.
    Pelidou SH; Zou LP; Deretzi G; Oniding C; Mix E; Zhu J
    Exp Neurol; 2000 May; 163(1):165-72. PubMed ID: 10785455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease patterns in experimental allergic neuritis (EAN) in the Lewis rat. Is EAN a good model for the Guillain-Barré syndrome?
    Brosnan JV; King RH; Thomas PK; Craggs RI
    J Neurol Sci; 1988 Dec; 88(1-3):261-76. PubMed ID: 3265717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement depletion suppresses Lewis rat experimental allergic neuritis.
    Feasby TE; Gilbert JJ; Hahn AF; Neilson M
    Brain Res; 1987 Sep; 419(1-2):97-103. PubMed ID: 3499953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biphasic form of experimental autoimmune neuritis in dark Agouti rats and its oral therapy by antigen-specific tolerization.
    Jung S; Gaupp S; Korn T; Köllner G; Hartung HP; Toyka KV
    J Neurosci Res; 2004 Feb; 75(4):524-35. PubMed ID: 14743436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prednisolone therapy of experimental allergic neuritis in Lewis rats does not induce relapsing or chronic disease.
    Stevens A; Schabet M; Wiethölter H; Schott K
    J Neuroimmunol; 1990 Jul; 28(2):141-51. PubMed ID: 2362015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of experimental allergic neuritis in the BN rat: P2 protein-specific T cells overcome resistance to actively induced disease.
    Linington C; Mann A; Izumo S; Uyemura K; Suzuki M; Meyermann R; Wekerle H
    J Immunol; 1986 Dec; 137(12):3826-31. PubMed ID: 2431045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane attack complex of complement is not essential for immune mediated demyelination in experimental autoimmune neuritis.
    Tran GT; Hodgkinson SJ; Carter NM; Killingsworth M; Nomura M; Verma ND; Plain KM; Boyd R; Hall BM
    J Neuroimmunol; 2010 Dec; 229(1-2):98-106. PubMed ID: 20850187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive effect of FK506 on experimental allergic neuritis in Lewis rats: change of T cell subsets.
    Adachi A; Araga S; Takahashi K
    Intern Med; 1992 Jan; 31(1):6-10. PubMed ID: 1373661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of TLR4 and TLR9 mRNA in Lewis rats with experimental allergic neuritis.
    Deng YN; Zhou WB
    Neuroimmunomodulation; 2007; 14(6):337-43. PubMed ID: 18434754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attempts to suppress experimental allergic neuritis in the rat by pretreatment with antigen.
    Brosnan JV; Craggs RI; King RH; Thomas PK
    Acta Neuropathol; 1984; 64(2):153-60. PubMed ID: 6332448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of experimental allergic neuritis in the Lewis rat with bovine P2 protein.
    Cunningham JM; Powers JM; Brostoff SW
    Brain Res; 1983 Jan; 258(2):285-9. PubMed ID: 6186335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attempts to transfer experimental allergic neuritis with lymphocytes.
    Brosnan JV; Craggs RI; King RH; Thomas PK
    J Neuroimmunol; 1984; 6(6):373-85. PubMed ID: 6480819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.